Search

Search Results

• 

  Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

  Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman

  27-11-2024

  250

  PDF: 123
• 

  Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern

  Giovanni L. Tiscia, Donatella Colaizzo, Antonio De Laurenzo, Filomena Cappucci, Lucia Fischetti, Elena Chinni, Mario Mastroianno, Giovanni Favuzzi, Massimo Carella, Elvira Grandone

  22-10-2024

  1345

  PDF: 226

  Supplementary: 176
• 

  Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

  Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti

  01-12-2022

  1338

  PDF: 266
• 

  The new era of anticoagulation: factor XI and XII inhibitors

  Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

  07-06-2023

  1874

  PDF: 801
• 

  A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

  Sergio Coccheri

  24-10-2022

  1618

  PDF: 245
• 

  Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques?

  Marcello Baroni, Paolo Ferraresi, Nicole Ziliotto, Daria Bortolotti, Pierfilippo Acciarri, Nicola Martinelli, Giovanna Marchetti, Matteo Coen, Francesco Bernardi

  17-10-2022

  2018

  PDF: 190

• The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

  Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

  04-09-2024

  641

  PDF: 150

  SUPPLEMENTARY MATERIAL: 79
• 

  Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

  Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

  17-10-2022

  2180

  PDF: 220

  Supplementary Files: 49
• 

  Gene transfer in hemophilia B: a big step forward

  Giancarlo Castaman

  17-05-2023

  807

  PDF: 233
• 

  Endothelial cell dysfunction in cancer: a not-so-innocent bystander

  Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

  16-05-2024

  1011

  PDF: 166
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  591

  PDF: 329
• 

  Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

  Nadim Tawil, Lata Adnani, Janusz Rak

  16-05-2024

  308

  PDF: 124
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  917

  PDF: 314

  APPENDIX: 60
• 

  The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

  Armando Tripodi

  23-01-2025

  36

  PDF: 10
• 

  Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

  Roberta Parisi, Simona Costanzo, Romy de Laat-Kremers, Augusto Di Castelnuovo, Amalia De Curtis, Teresa Panzera, Mariarosaria Persichillo, Chiara Cerletti, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Bas de Laat , for the Moli-sani Study Investigators

  27-01-2023

  1480

  PDF: 370

  APPENDIX: 68
• 

  Influence of emicizumab on protein C-mediated clotting regulation

  Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  25-10-2023

  1884

  PDF: 198

  Supplementary Material: 34
• 

  The changing landscape of treatment for acquired hemophilia A

  Massimo Franchini, Daniele Focosi

  30-01-2025

  0

  PDF: 0
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  693

  PDF: 288
• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  1247

  PDF: 415
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  1132

  PDF: 253

  Supplementary File: 128